Immunotherapy for prostate cancer: Lessons from responses to tumor-associated antigens

Immunotherapy for prostate cancer: Lessons from responses to tumor-associated antigens

Prostate cancer is the most common cancer in men and the second most common cause of cancer-related death in men. In recent years, novel therapeutic options for prostate cancer have been developed and studied extensively in clinical trials. Sipuleucel-T is the first cell-based immunotherapeutic vacc...

Full description

Bibliographic Details
Main Authors: Harm eWestdorp, Annette E. Skold, Berit A. Snijer, Sebastian eFranik, Sasja F. Mulder, Pierre Paul Major, Ronan eFoley, Winald R. Gerritsen, I. Jolanda M. de Vries
Format: Article
Language:English
Published: Frontiers Media S.A. 2014-05-01
Series:Frontiers in Immunology
Subjects:
Immunotherapy
prostate cancer
crpc
Tumor-associated antigens
immunotherapy of cancer
Online Access:http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00191/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00191/full

Similar Items